US people to pay for medicine levies

The Trump administration's threat to impose extra tariffs on crude drugs manufactured in China will ultimately harm the interests of the American people, who will have to pay more for the final products made by local firms in the United States, said a leading industry analyst.

Medicines and health products account for approximately 30 percent of the total products on which the US authorities threatened to levy extra tariffs, according to the China Chamber of Commerce for Import and Export of Medicines and Health Products.

The chamber added that the customs tariff codes for export commodities are different between the Chinese and US customs.